东瑞制药(02348.HK)：胡硕获委任为非执行董事
Group 1 - The core point of the article is the appointment of Hu Shuo as a non-executive director of Dongrui Pharmaceutical, effective from August 1, 2025 [1]
Group 1 - The core point of the article is the appointment of Hu Shuo as a non-executive director of Dongrui Pharmaceutical, effective from August 1, 2025 [1]